Medican Moves Toward Closing The Purchase Of 51 Percent Of International Herbs Medical Marijuana Ltd. (IHMML)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises, Inc. (OTCBB:MDCN), a bio-pharmaceutical company focused on manufacturing and selling pharmaceutical grade cannabis in Canada, continues to update the public on its acquisition of a 51% interest in International Herbs Medical Marijuana Ltd. (IHMML).

IHMML is a Canadian company that has applied for a commercial medical marijuana license under the recently established Canadian Marihuana for Medical Purposes Regulations (MMPR). The MMPR came into effect on April 1, 2014 and is a federal program that legalizes the commercial production of medical marijuana for medical use. IHMML is currently owned by Zenabis Limited Partnership, a Canadian partnership owned by affiliates of International Herbs Ltd. (IHL), a leader in the production of fresh herbs and specialty produce in Canada, and The Monark Group (Monark). The IHL and Monark teams are integral to establishing IHMML’s contemplated business, namely, to acquire certain lands, retrofit and/or build a marijuana growing operation and engage in the growing, research and development, training, distribution and retail sale of medical marijuana in Canada as regulated by Health Canada.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC